AEHR Test Systems CFO’s recent $84.64 share sale shows routine liquidity moves, not a market shift—focus on tech trends, consolidation, and upcoming guidance for true valuation insights.
AEHR Test Systems insider sales show a pattern of modest portfolio rebalancing—investors should watch for larger moves that could signal shifts in confidence and volatility.